Jpmorgan Chase & Co (JPM) Holding Increased by Brown Advisory Securities Llc; As Galmed Pharmaceuticals LTD (GLMD) Stock Declined, 683 Capital Management Upped Its Position by $900,000

May 26, 2018 - By Hazel Jackson

JPMorgan Chase & Co. (NYSE:JPM) Logo

683 Capital Management Llc increased its stake in Galmed Pharmaceuticals Ltd (GLMD) by 18.21% based on its latest 2017Q4 regulatory filing with the SEC. 683 Capital Management Llc bought 100,000 shares as the company’s stock declined 42.08% with the market. The hedge fund held 649,295 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $5.94 million, up from 549,295 at the end of the previous reported quarter. 683 Capital Management Llc who had been investing in Galmed Pharmaceuticals Ltd for a number of months, seems to be bullish on the $92.92M market cap company. The stock increased 0.33% or $0.02 during the last trading session, reaching $6.02. About 21,803 shares traded. Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) has risen 11.79% since May 26, 2017 and is uptrending. It has outperformed by 0.24% the S&P500.

Brown Advisory Securities Llc increased its stake in Jpmorgan Chase & Co (JPM) by 5.71% based on its latest 2017Q4 regulatory filing with the SEC. Brown Advisory Securities Llc bought 3,472 shares as the company’s stock rose 0.67% while stock markets declined. The institutional investor held 64,245 shares of the major banks company at the end of 2017Q4, valued at $6.87M, up from 60,773 at the end of the previous reported quarter. Brown Advisory Securities Llc who had been investing in Jpmorgan Chase & Co for a number of months, seems to be bullish on the $376.72B market cap company. The stock decreased 0.51% or $0.57 during the last trading session, reaching $110.66. About 8.28M shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 23.99% since May 26, 2017 and is uptrending. It has outperformed by 12.44% the S&P500.

Brown Advisory Securities Llc, which manages about $869.60M and $518.58M US Long portfolio, decreased its stake in Vanguard Index Fds (VNQ) by 6,813 shares to 21,852 shares, valued at $1.81 million in 2017Q4, according to the filing. It also reduced its holding in Vanguard Specialized Funds (VIG) by 3,252 shares in the quarter, leaving it with 7,446 shares, and cut its stake in Kinder Morgan Inc Del (NYSE:KMI).

Since January 13, 2018, it had 3 buys, and 8 insider sales for $18.63 million activity. Shares for $7.31M were sold by Erdoes Mary E.. On Saturday, January 13 the insider Lake Marianne sold $1.03M. Shares for $425,399 were sold by Giles Nicole. Another trade for 17,729 shares valued at $1.99M was sold by Friedman Stacey. Another trade for 26,532 shares valued at $3.01M was made by Scher Peter on Friday, January 19. $1.84 million worth of JPMorgan Chase & Co. (NYSE:JPM) shares were sold by BACON ASHLEY.

Among 34 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 14 Hold. Therefore 53% are positive. JPMorgan Chase & Co had 120 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Thursday, April 14 by Nomura. Argus Research maintained it with “Buy” rating and $70 target in Monday, January 18 report. Jefferies maintained the stock with “Buy” rating in Friday, July 7 report. Oppenheimer maintained the stock with “Hold” rating in Friday, July 14 report. As per Monday, October 10, the company rating was maintained by Jefferies. As per Wednesday, July 13, the company rating was initiated by Berenberg. The firm has “Neutral” rating given on Monday, January 25 by Nomura. As per Friday, October 6, the company rating was maintained by BMO Capital Markets. The firm earned “Hold” rating on Tuesday, December 12 by Keefe Bruyette & Woods. The firm earned “Hold” rating on Wednesday, January 17 by DZ Bank.

More notable recent JPMorgan Chase & Co. (NYSE:JPM) news were published by: Seekingalpha.com which released: “JPMorgan Going From Strength To Strength” on May 14, 2018, also Investorplace.com with their article: “Wells Fargo & Co Stock Is a Rough Diamond — Go Long” published on May 25, 2018, Benzinga.com published: “Benzinga’s Insider Buys Of The Week: JPMorgan, Philip Morris And More” on May 20, 2018. More interesting news about JPMorgan Chase & Co. (NYSE:JPM) were released by: Seekingalpha.com and their article: “JPMorgan ups automated stock trading efforts” published on May 10, 2018 as well as Seekingalpha.com‘s news article titled: “JPMorgan doubles down on AI” with publication date: May 04, 2018.

Investors sentiment decreased to 0.88 in Q4 2017. Its down 0.03, from 0.91 in 2017Q3. It is negative, as 55 investors sold JPM shares while 802 reduced holdings. 142 funds opened positions while 611 raised stakes. 2.46 billion shares or 1.60% less from 2.50 billion shares in 2017Q3 were reported. Schwab Charles Investment Mgmt Incorporated invested 1.08% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Ls Limited Liability holds 0.82% or 131,661 shares in its portfolio. Veritas Invest Management (Uk) owns 2,300 shares. The New York-based Sanders Cap Lc has invested 3.68% in JPMorgan Chase & Co. (NYSE:JPM). Dillon & Assocs Inc reported 0.72% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Two Sigma owns 12,457 shares for 0.04% of their portfolio. Essex Financial stated it has 64,928 shares. Grand Jean Mgmt has invested 1.01% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Destination Wealth Mngmt owns 10,352 shares. Phillips Mgmt holds 0.31% or 13,423 shares in its portfolio. Mirae Asset Glob has 918,339 shares for 1.31% of their portfolio. Karpus Mgmt stated it has 0.01% in JPMorgan Chase & Co. (NYSE:JPM). Hamel Associates reported 0.28% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). 60,000 are held by Cincinnati Finance Corp. Chickasaw Cap Mgmt Ltd Llc reported 1,975 shares.

683 Capital Management Llc, which manages about $566.08 million and $1.19B US Long portfolio, decreased its stake in Kkr & Co LP Del (NYSE:KKR) by 388,700 shares to 1.00M shares, valued at $21.06M in 2017Q4, according to the filing. It also reduced its holding in Inspired Entmt Inc by 46,106 shares in the quarter, leaving it with 298,209 shares, and cut its stake in Dicerna Pharmaceuticals Inc (NASDAQ:DRNA).

JPMorgan Chase & Co. (NYSE:JPM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: